《大行报告》花旗:港交所(00388.HK)去年第四季核心收入及EBIT逊预期
花旗发表报告指,港交所(00388.HK)去年第四季纯利为20亿元,按季下跌10%,按年则升9%,表现逊於市场预期5%。而集团去年第四季核心收入亦逊预期,按季及按年跌7%,逊预期2%。期内营运支出按季及按年升5%,较市场预期高9%,部分原因是折旧较高,故此,EBITDA大致符预期,但该季EBIT较预期低5%。
该行表示,即使已计及日均成交下降的因素,港交所去年第四季盈利表现仍然疲弱,而正面的是年初至今的日均成交对比去年首季有见9%的增长。
花旗维持对港交所的「沽售」评级及目标价220元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.